strong start fiscal expect momentum continu
morn report fiscal first quarter result beat estim
top- bottom line constant currenc revenu ep growth guidanc
increas well overal nice beat-and-rais quarter start year believ
come compani diabet busi see strong traction
sensor-aug pump believ still long runway front
technolog entranc stand-alon cgm market also help
franchis come quarter believ upsid estim may exist
number new technolog either recent enter soon
avail also boost top-lin growth coupl profil
improv oper margin outlook excel believ investor
continu name level
fiscal result top estim report fiscal first quarter result morn
beat estim top- bottom line total sale
organ beat street target diabet franchis
clear standout quarter deliv growth cc basi driven strong
uptak adjust ep beat estim six cent though lower
tax rate favor currenc contribut four cent beat oper margin
essenti flat compar last year manag took advantag revenu
strength acceler spend neg mix shift felt gm
guidanc fiscal rais follow strong result manag rais
revenu outlook compani organ constant currenc
level comfort around higher end rang diabet
busi primari reason heighten top-lin outlook though rest
busi continu deliv solid growth compani reiter expect
bp underli oper margin expans close full
year given neg currenc headwind manag decid keep ep
rang cc growth rate increas bp
point call perform diabet franchis impress
repres best growth busi last decad cgm
manufactur issu behind compani perform sensor-
augment pump benefit result compani move
stand-alon cgm market anticip bolster perform
franchis come quarter continu next page
slowdown key market competit pressur regulatori delay
largest medic technolog compani global diversifi product offer
cardiolog surgeri spine neurolog diabet
cy ep
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
overal expect diabet carri highest growth rate next coupl year
separ manag note acceler spend quarter take
advantag revenu out-performance spend went intrigu larg market
area includ hypertens total mitral valv repair sooner address
categori efficaci technolog better view top-lin outlook
stock follow three straight quarter better-than-expect financi
perform share lift nice far year said spate compel
new product either market soon hit continu see solid revenu growth
compani leverag bottom line deliv high-singl low-double-digit ep
growth anticip dynam allow stock continu climb higher
keep us construct name
pt increas roll forward pt multipl ep
previous base repres multipl consist previou
pt comp group trade ep expect level grind higher
given strong revenu growth outlook oper leverag translat
high-single-digit low-double-digit ep growth
page
page
good gener expens incom net incom tax net incom analysi gross gener segment analysi cardiac rhythm heart structur peripher cardiac vascular gastrointestin minim invas therapi restor therapi diabet revenu unadjust million medtron plc
million except per share data
good sold
percent sale
good sold
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
